TrialSpark procures $156m Series C
TrialSpark, a tech-driven pharma company, has raised $156 million in Series C funding.
TrialSpark, a tech-driven pharma company, has raised $156 million in Series C funding.
Copyright PEI Media
Not for publication, email or dissemination
